Press release
Antidiabetics Market share to grow at 10% CAGR from 2016 to 2023
Global Market Insights, Inc.
Aging and obesity are the key risk factors for diabetes, with affected population slated to exceed 360 million by 2023. Major diabetes consequences include blindness, amputations, and kidney failure, with higher risk of death. Increasing geriatric population, and rising obesity trend along with rising patient awareness levels are some pivotal drivers for industry growth. Global insulin antidiabetics market size was valued at USD 51.1 billion in 2015, with 10.9% CAGR gains likely during forecast period.
Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/504
A number of initiatives aimed at providing insulin and other anti-diabetic drugs to patients at a cost-effective price by establishing sophisticated healthcare reimbursement network is a key global trend. Apart from this, introduction of new high-efficiency products is also expected to boost growth.
Technology growth with products such as rapid acting, and long acting insulin analogs with higher efficacies, ultra-long acting SGLT-2 inhibitor analogs, and oral antidiabetics should further contribute to industry growth. The new insulin pen technology launch enables low-pain and convenient daily injection of insulin should also propel spur therapy sales.
Generic drug manufacturers could tap the growth opportunity due to patent expiration of major popular products by introducing low cost and effective products. Moreover, emerging regions also offer a strong platform with unmet medical needs. Growing prevalence, large diabetic patient pool, and increasing awareness levels regarding diagnosis in the emerging Asia Pacific countries are some reasons for industry growth expectations. APAC was driven by the countries Japan, China and India antidiabetics market size, estimated at USD 28 billion by 2023.
Browse key industry insights spread across 71 pages with 36 market data tables & 30 figures & charts from the report Antidiabetics Market in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/antidiabetics-market
Key insights from the report include:
• Global antidiabetics market size was USD 51.1 billion in 2015, with over 10% industry gains up to 2023.
• U.S. insulin antidiabetics market share was the largest in North America, with close to 24 million estimated diabetes patients, of which 23% remain undiagnosed. Various awareness campaigns and education programs are organized by associations and diabetes societies to raise awareness and provide information regarding diabetes management.
• However, the U.S. is maturing in terms of new product launches, due to which manufacturers are now seeking towards emerging areas in diabetes for more revenue generation.
• Europe antidiabetics market will show steady growth as well, particularly due to increase in obesity prevalence, with 10% to 50% of adult population diagnosed to be obese in 2015. Germany and UK insulin antidiabetic sales accounted for more than 50% of regional revenue.
• Asia Pacific could see 13% CAGR sales growth from 2016 to 2023, with India and China still relatively unexplored in terms of potential.
• Takeda, Merck, Boehringer Ingelheim, Oramed, Pfizer, Novo Nordisk, Eli Lilly and Sanofi Aventis, are some notable industry participants.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/504
Global Market Insights has segmented the antidiabetics industry on the basis of product, application, and region:
Global Antidiabetics Market Product Analysis (Revenue, USD Million; 2012 - 2023)
• Insulin
o Rapid Acting
o Long Acting
o Premixed
o Short Acting
o Intermediate Acting
• Other Antidiabetics
o Alpha-Glucosidase Inhibitors
o Biguanides
o Sulphonylureas
o GLP-1 Agonist
o Meglitinides
o DPP-4 Inhibitors
o SGLT-2
o Thiazolodinediones
Global Antidiabetics Market Application Analysis (Revenue, USD Million; 2012 - 2023)
• Type I
• Type II and Other Diabetes
Antidiabetics Market Regional Analysis (Revenue, USD Million, 2012 – 2023)
• North America
• Europe
• Asia Pacific
• LATAM
• MEA
Browse Related Reports:
• Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
https://www.gminsights.com/industry-analysis/precision-medicine-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market share to grow at 10% CAGR from 2016 to 2023 here
News-ID: 513785 • Views: …
More Releases from Global Market Insights, Inc.
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products.
Prenatal vitamin ingredients can…
More Releases for Acting
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American…
Antidiabetic Thiazolidinediones Market to Grow from USD 40.56 billion in 2014 to …
The research report analyzes the Global Antidiabetic Thiazolidinediones Market in a thorough manner by clarifying the key characteristics of the market that are anticipated to have a measureable influence on its evolving prospects over the forecast period. The major growth drivers, challenges, and trends influencing the market are examined at length. A thorough qualitative and quantitative data pertaining to the projected impact of these factors on market’s future growth prospects…
Antidiabetic Thiazolidinediones Market Report by Size By Product (Insulin [Rapid …
This report presents a 360-degree overview of the competitive scenario and projects the size and valuation of the global Antidiabetic Thiazolidinediones market in the coming forecast period. The report also presents a thorough qualitative and quantitative data affecting to the projected impact of these factors on market’s future growth prospects.
The competitive landscape section of the report presents the key vendors operating in the Global Antidiabetic Thiazolidinediones Market. These competitors are…
Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting …
The research report states that the global and China insulin market is expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global and China insulin market is segmented on the basis of mode of action and source. The modes of action seen in the insulin market are rapid-acting, long-acting, short-acting, intermediate-acting, and…
Opening of Michelle Danner Los Angeles Acting School and New York Acting School
New York, USA (October 25, 2012)– The Michelle Danner Acting School in Los Angeles is expanding into New York with the opening of a new conservatory, which will offer a six and twelve-month Well Rounded Actor’s Training Intensive.
The program at the Michelle Danner Acting School includes The Golden Box for actors. This world-class acting intensive is a two-day workshop that teaches the actor how to create fleshed-out and interesting characters…
